<DOC>
	<DOCNO>NCT00348361</DOCNO>
	<brief_summary>This study aim validate key therapeutic target biomarkers associate allergic rhinitis . The therapeutic target expression investigate 7 day course corticosteroid treatment follow allergen challenge .</brief_summary>
	<brief_title>Exploration Of Key Targets And Biomarkers Involved In An Allergic Response In Subjects With Allergic Rhinitis ( Hay Fever )</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Inclusion criterion : No sign symptom rhinitis outside relevant airborne allergen season . Exclusion criterion : History current evidence upper low respiratory infection symptom ( include common cold ) within 2 week baseline assessment . Symptoms rhinitis inclusion indicate total VAS score &gt; 40 combine symptom score blockage , rhinorrhoea , sneeze , itch ) single symptom VAS score &gt; 20 . Subjects show nasal response allergen concentration = &lt; 10,000 BU/ml . Subjects positive skin prick test Dust House Mite .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Hay fever</keyword>
	<keyword>biomarkers</keyword>
</DOC>